Table 2 |
|||||||
|
The number of patients who had initial and six-month follow-up serum 25-hydroxyvitamin D (25-OHD) taken as part of their Health Assessment in general practice n = 266 patients |
|||||||
|
Number of patients with initial 25-OHD levels* |
% |
Follow up 25-OHD levels at six months |
|||||
|
|
|||||||
|
Low |
Borderline |
Normal |
Total followed |
% |
|||
|
|
|||||||
|
Low |
89 |
33.5% |
19 |
32 |
5 |
56 |
63% |
|
Borderline |
109 |
41% |
1 |
1 |
1 |
3 |
3% |
|
Normal |
68 |
26% |
- |
- |
- |
0 |
0% |
|
|
|||||||
|
*Low 25-hydroxyvitamin D = < 51 nmol/l, Borderline 25-hydroxyvitamin D = 51-79 nmol/l, Normal 25-hydroxyvitamin D = 80+ nmol/l |
|||||||
|
Kljakovic et al. Asia Pacific Family Medicine 2012 11:3 doi:10.1186/1447-056X-11-3 |
|||||||